Abstract
Nicotine dependence plays a critical role in addiction to tobacco products, and thus contributes to a variety of devastating tobacco-related diseases (SGR 2014). Annual costs associated with smoking in the US are estimated to be between $289 and $333 billion. Effective interventions for nicotine dependence, especially in smokers, are a critical barrier to the eradication of tobacco-related diseases. This overview highlights research presented at the Plenary Symposium of Behavior, Biology and Chemistry: Translational Research in Addiction Conference (BBC), hosted by the UT Health Science Center San Antonio, on March 9-10, 2013. The Plenary Symposium focused on tobacco addiction, and covered topics ranging from basic science to national policy. As in previous years, the meeting brought together globally-renowned scientists, graduate student recruits, and young scientists from underrepresented populations in Texas and other states with the goal of fostering interest in drug addiction research in young generations.
| Original language | English |
|---|---|
| Pages (from-to) | 107-117 |
| Number of pages | 11 |
| Journal | Drug and Alcohol Dependence |
| Volume | 141 |
| DOIs | |
| State | Published - Aug 1 2014 |
Bibliographical note
Funding Information:This manuscript is based on a symposium given at the 2013 Behavior, Biology and Chemistry: Translational Research in Addiction meeting, which was supported in part by grant R13DA029347 from the National institute on Drug Abuse .
Funding Information:
Work discussed in the manuscript was supported in part by the following NIH grants: DA017173 , DA024385 , U19CA148127 to MDB; U19DA017548 to PC, LPD & MTB; DA10714 to PP; U19CA157345 and U54DA03165 to DH. The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
Funding
This manuscript is based on a symposium given at the 2013 Behavior, Biology and Chemistry: Translational Research in Addiction meeting, which was supported in part by grant R13DA029347 from the National institute on Drug Abuse . Work discussed in the manuscript was supported in part by the following NIH grants: DA017173 , DA024385 , U19CA148127 to MDB; U19DA017548 to PC, LPD & MTB; DA10714 to PP; U19CA157345 and U54DA03165 to DH. The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | DA10714, U54DA03165, U19CA157345, DA017173, U19CA148127 |
| National Institutes of Health (NIH) | |
| National Institute on Drug Abuse | R21DA024385, U19DA017548, R13DA029347 |
| National Institute on Drug Abuse |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Nicotine dependence
- Nicotine vaccine
- Nicotine withdrawal
- Nicotinic receptor antagonists
- Smoking cessation
- Tobacco product regulation
ASJC Scopus subject areas
- Toxicology
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Scientific overview: 2013 BBC plenary symposium on tobacco addiction'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver